STOCK TITAN

Humana Stock Price, News & Analysis

HUM NYSE

Welcome to our dedicated page for Humana news (Ticker: HUM), a resource for investors and traders seeking the latest updates and insights on Humana stock.

Humana Inc. (HUM) is a leading health insurance provider specializing in government-sponsored healthcare programs and integrated wellness solutions. This dedicated news hub provides investors and industry professionals with timely updates on corporate developments, financial performance, and strategic initiatives shaping the healthcare sector.

Access authoritative information through verified press releases covering earnings announcements, Medicare Advantage plan expansions, Medicaid service updates, and partnerships in primary care innovation. Track regulatory filings related to prescription drug plans and pharmacy benefit management services critical to HUM's operations.

Key updates include insights into value-based care models, military health program (TRICARE) enhancements, and advancements in at-home healthcare services. All content is sourced directly from company communications to ensure accuracy for financial analysis and market trend evaluation.

Bookmark this page for streamlined access to HUM's latest operational milestones and healthcare industry leadership updates. Check regularly for objective reporting on developments impacting one of America's largest managed care organizations.

Rhea-AI Summary

Humana Inc. (NYSE: HUM) and Aledade have announced a 10-year partnership aimed at enhancing value-based primary care for Medicare Advantage members. This collaboration builds on a successful relationship since 2019, which resulted in a 5% reduction in hospitalizations and 12% decrease in readmissions. By 2022, over 100,000 patients benefited from this value-based approach. The partnership will gradually expand through existing and new agreements, focusing on comprehensive care and risk sharing. Aledade aims to empower independent practices with technology and support, having generated over $1.2 billion in healthcare savings to date.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.08%
Tags
none
-
Rhea-AI Summary

AM Best has assigned a Long-Term Issue Credit Rating of bbb- (Good) to Humana's recent $500 million, 5.7% senior unsecured notes due March 13, 2026 and $750 million, 5.5% senior unsecured notes due March 15, 2053. The outlook for these ratings is stable. The issuance aims to replace existing term loans, pre-fund upcoming maturities, and support general corporate purposes. Humana's financial leverage was approximately 42% as of Dec. 31, 2022, which is expected to moderate to about 40% long-term. Despite elevated leverage, earnings before interest and taxes coverage remains strong at over 10 times.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.23%
Tags
none
-
Rhea-AI Summary

Humana Inc. (NYSE: HUM) announced a public offering of $1.25 billion in senior notes, comprised of $500 million due 2026 and $750 million due 2053. Pricing was set at 99.984% and 96.431% of the principal amount respectively. The offering is expected to close on March 13, 2023. Net proceeds, estimated at $1.211 billion, will repay a $500 million Delayed Draw Term Loan and cover general corporate purposes. The company is also vulnerable to various financial risks and regulatory changes, impacting profitability and operations, particularly due to its heavy government contract reliance.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.27%
Tags
none
Rhea-AI Summary

Humana Inc. (NYSE: HUM) has announced that President and CEO Bruce D. Broussard will present to investors at the Cowen Health Care Conference on Tuesday, March 7, 2023, at 9:10 a.m. Eastern time. Investors can access a live audio webcast of the presentation on Humana's Investor Relations page, with a recommendation to log in 15 minutes early for system testing.

Humana is dedicated to improving health and well-being for its medical and specialty members while lowering costs. The company offers various clinical capabilities, including in-home care, behavioral health, and wellness solutions, aiming to simplify health care navigation for patients.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.63%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.4%
Tags
none
-
Rhea-AI Summary

Humana Inc. (NYSE: HUM) has declared a cash dividend of $0.885 per share, an increase of 12.4% from the previous $0.7875. The dividend is payable on April 28, 2023 to stockholders of record as of March 31, 2023. This reflects Humana's commitment to providing value to its shareholders while supporting integrated healthcare solutions. The company focuses on improving healthcare quality through in-home care, behavioral health, pharmacy services, and data analytics. Additional information is available on Humana's investor relations page.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.48%
Tags
dividends
Rhea-AI Summary

Humana Inc. (NYSE: HUM) announces the Humana Foundation's new strategy aimed at advancing health equity by removing barriers in healthcare for seniors, veterans, and school-aged children. The Foundation will invest over $15 million in community partners and evidence-based programs, focusing on emotional connections and healthier nutrition. Notably, the Health Equity Innovation Fund has been established with $7.5 million to tackle chronic diseases. Initial grants include support for the UNC Eshelman Institute for Innovation and regional nutrition programs, enhancing access to healthier food options.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.67%
Tags
none
-
Rhea-AI Summary

Humana Inc. (NYSE: HUM) has reinforced its long-standing relationship with ChenMed by signing a new five-year agreement, allowing Humana’s Medicare Advantage members access to in-network care at all of ChenMed’s locations. This collaboration supports both companies' commitment to senior-focused primary care, ensuring high-quality healthcare for members across Florida and beyond. Humana has approximately 8.6 million Medicare members, with 5.6 million enrolled in Medicare Advantage plans. The agreement further enhances ChenMed’s capabilities in delivering personalized concierge care, ensuring improved health outcomes for seniors.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.75%
Tags
none
-
Rhea-AI Summary

Humana's Kentucky Medicaid Plan, Humana Healthy Horizons, announced a grant of $120,000 to three local organizations to enhance maternal health for Black mothers in Louisville. This initiative aims to address significant barriers, including access to prenatal care, reflected in Kentucky's low maternal health ratings. Black women experience a 2.9 times higher maternal mortality rate than white women in the U.S., underscoring the need for these efforts. The grants will support telehealth services, transportation for appointments, and training for community doulas, contributing to health equity in the region.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.07%
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.31%
Tags
none

FAQ

What is the current stock price of Humana (HUM)?

The current stock price of Humana (HUM) is $256.62 as of August 6, 2025.

What is the market cap of Humana (HUM)?

The market cap of Humana (HUM) is approximately 30.6B.
Humana

NYSE:HUM

HUM Rankings

HUM Stock Data

30.61B
119.97M
0.21%
97.97%
3.56%
Healthcare Plans
Hospital & Medical Service Plans
Link
United States
LOUISVILLE